Dr. Candice Schwartz, MD

Dr. Schwartz practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Schwartz's NPI, 1194104083, was assigned on May 25, 2015. Dr. Schwartz graduated from Wake Forest School of Medicine in 2015. Dr. Schwartz holds Florida license 149553.

Dr. Schwartz's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Schwartz's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Schwartz is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Schwartz to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schwartz is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Schwartz's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists breast cancer, chronic anemia and purpura and thrombocytopenia among the conditions Dr. Schwartz treats.

CMS data shows 345 Medicare services from Dr. Schwartz across 4 procedure codes in 2024, for 96 Medicare patients. Medicare paid $30,314 for them.

CMS counts 96 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 65, with 96% women.

In 2024, Dr. Schwartz wrote 361 Medicare Part D claims for 110 patients. 77% of them were for generic drugs. CMS names the drug for 204 of them, across 7 drugs with 11 or more claims each, at $489,605 in total drug cost. In 2023, CMS named 298 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Schwartz for performance year 2024, reported through an alternative payment model (APM). Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwartz as offering telehealth.

Dmand AI links 11 papers to Dr. Schwartz, published from 2011 to 2022. 2011 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Breast Neoplasms and Cell Line, Tumor. Dr. Schwartz's most frequent co-authors are Ivy Elizabeth Abraham, Timothy M. Kuzel, MD and Samuel Matthew Rubinstein, MD.

CMS Open Payments shows 48 general payments to Dr. Schwartz from 25 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $129.

Dr. Schwartz graduated from Wake Forest School of Medicine in 2015.

Dr. Schwartz is in network with 12 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.